rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1994-5-6
|
pubmed:abstractText |
A new anti-human immunodeficiency virus type 1 and 2 (anti-HIV 1 and 2) test is described. It uses recombinant p24 and peptides covering gp32, gp41, and gp120 to identify HIV-1 and HIV-2 infections. This test has been shown to be specific (99.5%) and sensitive (99.8%). In this respect, the assay was equal or superior to anti-HIV 1 and 2 tests run as references. The test was able to discriminate sera from patients with HIV infections from those from uninfected individuals with excellence; it also exerted high intra- and interassay precisions. The "modular" concept of the test allows the use of single components (gp32 or gp41) to separate between HIV-2 and HIV-1 infections, respectively.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/8150950-1786625,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8150950-2183814,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8150950-2202798,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8150950-2654429,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8150950-2880053,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8150950-2882109,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8150950-2882276,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8150950-2893030,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8150950-2927478,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8150950-3145873,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8150950-3146278,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8150950-3340847,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8150950-3548705,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8150950-572747,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8150950-90074
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0095-1137
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
403-6
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:8150950-Diagnosis, Differential,
pubmed-meshheading:8150950-Evaluation Studies as Topic,
pubmed-meshheading:8150950-Female,
pubmed-meshheading:8150950-HIV Antibodies,
pubmed-meshheading:8150950-HIV Antigens,
pubmed-meshheading:8150950-HIV Infections,
pubmed-meshheading:8150950-HIV Seropositivity,
pubmed-meshheading:8150950-HIV-1,
pubmed-meshheading:8150950-HIV-2,
pubmed-meshheading:8150950-Humans,
pubmed-meshheading:8150950-Immunoenzyme Techniques,
pubmed-meshheading:8150950-Male,
pubmed-meshheading:8150950-Pregnancy,
pubmed-meshheading:8150950-Recombinant Proteins,
pubmed-meshheading:8150950-Sensitivity and Specificity
|
pubmed:year |
1994
|
pubmed:articleTitle |
Diagnosis of human immunodeficiency virus (HIV) infection: multicenter evaluation of a newly developed anti-HIV 1 and 2 enzyme immunoassay.
|
pubmed:affiliation |
Medizinische Klinik und Poliklinik, Klinikum der Johannes-Gutenberg-Universität, Mainz, Germany.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Multicenter Study
|